Back to search

Article

Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy

2022-09-22

Abstract excerpt

<h4>Background: </h4> Previous investigations suggest that systemic inflammation markers are able to provide prognostic value in several cancers. This study seeks to characterize the ability of pretreatment platelet-to-lymphocyte ratio (PLR) to prognosticate advanced or metastatic gastric cancer patients (AGC or MGC, respectively) receiving immunotherapy. <h4>Method: </h4> AGC and MGC patients exposed to PD-1 inh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
640eb65b-fe46-5940-89c2-6972bb5ddaec
DOI
10.21203/rs.3.rs-2079775/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapyDOI 10.21203/rs.3.rs-2079775/v1
Pretreatment Platelet-to-Lymphocyte Ratio (PLR) is associated with prognosis in gastric cancer patients with immunotherapySemantic proximity
Identification and validation of a novel survival prediction model based on the T cell phenotype in tumor immune microenvironment and peripheral blood for the prognosis in gastric cancerSemantic proximity
Development and Validation of a Predictive Model for Gastric Cancer Based on the Albumin-to-Neutrophil-to-Lymphocyte Ratio: A Retrospective Cohort StudySemantic proximity
Development and Validation of a Nomogram for Predicting Major Pathological Response Following Neoadjuvant Chemoimmunotherapy in Gastric CancerSemantic proximity
Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinomaSemantic proximity
Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinomaSemantic proximity
Predictive value of the biomarker of peripheral blood of NSCLC patients responding to anti-PD-1 treatmentSemantic proximity
The CD8⁺T/MDSC ratio: A novel prognostic and predictive biomarker for immunotherapy response in gastric cancerSemantic proximity
Prognostic value of the ratio of Interleukin-2 and Interleukin-10 in patients with hepatocellular carcinoma treated with anti-PD-1 therapySemantic proximity
Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancerSemantic proximity
Systemic Inflammatory Indices as Accessible Biomarkers for Intracranial Outcome and Prognosis in Driver Gene-Negative NSCLC with Brain Metastases Treated with First-Line ChemoimmunotherapySemantic proximity
Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor.Semantic proximity
Select a neighboring publication to make it the new centre.